Showing results (1-10 of 444) with videos related to

Sort By:
Pageof 45
Mini Reviews in Medicinal Chemistry|May 10, 2016
Desirable Properties for 3rd Generation Cyclooxygenase-2 InhibitorsMicky D Tortorella, Yanmei Zhang, John Talley
Clinical and Experimental Rheumatology|October 18, 2019
The "elusive DMOAD": Aggrecanase inhibition from laboratory to clinicAnne-Marie Malfait, Micky D Tortorella
ACS Medicinal Chemistry Letters|October 22, 2015
Synthesis and Evaluation of Novel Erlotinib-NSAID Conjugates as More Comprehensive Anticancer AgentsYanmei Zhang, Micky D Tortorella, Jinxi Liao, et al.
ACS Medicinal Chemistry Letters|October 15, 2014
Synthesis of Deuterated Benzopyran Derivatives as Selective COX-2 Inhibitors with Improved Pharmacokinetic PropertiesYanmei Zhang, Micky D Tortorella, Yican Wang, et al.
Current Rheumatology Reports|August 10, 2013
Genetically Engineered Mouse Models Reveal the Importance of Proteases as Osteoarthritis Drug TargetsRachel E Miller, Yongzhi Lu, Micky D Tortorella, et al.
The Journal of Biological Chemistry|April 17, 2002
Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilageAnne-Marie Malfait, Rui-Qin Liu, Kosei Ijiri, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 24, 2002
Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4)Micky D Tortorella, Rui-Qin Liu, Timothy Burn, et al.
Current Pharmaceutical Design|July 16, 2009
A review of the ADAMTS family, pharmaceutical targets of the futureMicky D Tortorella, Fransiska Malfait, Ruteja A Barve, et al.
Pageof 45